Breaking news FDA authorizes use of Biogen’s ALS treatment Aprile 25, 2023 The United States Food and Drug Administration approved on Tuesday Biogen’s treatment for an inherited form of amyotrophic lateral sclerosis (ALS), a rare form of the disease. Biogen’s drug t…
